1文献来源研究一:Li B T,Michelini F,Misale S,et al.HER2⁃mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers[J].Cancer Discov,2020,10(5):674-687.研究二:Mazieres J,Lafitte C,Ricordel C,...1文献来源研究一:Li B T,Michelini F,Misale S,et al.HER2⁃mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers[J].Cancer Discov,2020,10(5):674-687.研究二:Mazieres J,Lafitte C,Ricordel C,et al.Combination of trastuzumab,pertuzumab,and docetaxel in patients with advanced non⁃small⁃cell lung cancer harboring HER2 mutations:results from the IFCT⁃1703 R2D2 trial[J].J Clin Oncol,2022,40(7):719-728.展开更多
文摘1文献来源研究一:Li B T,Michelini F,Misale S,et al.HER2⁃mediated internalization of cytotoxic agents in ERBB2 amplified or mutant lung cancers[J].Cancer Discov,2020,10(5):674-687.研究二:Mazieres J,Lafitte C,Ricordel C,et al.Combination of trastuzumab,pertuzumab,and docetaxel in patients with advanced non⁃small⁃cell lung cancer harboring HER2 mutations:results from the IFCT⁃1703 R2D2 trial[J].J Clin Oncol,2022,40(7):719-728.
